Andrology in China: Current status and 10 years progress

Asian Journal of Andrology

Volumn 13, Issue 4, 2011, Pages 512-518

  Hong, Kai ^a   Xu, Qing Quan ^b   Zhao, Yong Ping ^b   Gu, Yi Qun ^c   Jiang, Hui ^a   Wang, Xiao Feng ^b   Zhu, Ji Chuan ^b  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

Author keywords

andrology; benign prostatic hyperplasia; Chinese; contraception; erectile dysfunction; male infertility; prostate cancer; prostatitis

Indexed keywords

ANDROLOGY; CHINA; CHINESE MEDICINE; CONTRACEPTION; ERECTILE DYSFUNCTION; MALE INFERTILITY; MALE SEXUAL DYSFUNCTION; PROSTATE DISEASE; REVIEW; SEXUAL HEALTH;

ANDROLOGY; CHINA; CONTRACEPTION; ERECTILE DYSFUNCTION; HUMANS; INFERTILITY, MALE; MALE; PROSTATIC DISEASES;

EID: 79960052146     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2010.123     Document Type: Review

References (63)

1. Zhang ZC, Sun B, Liu YS, Chen Q, Xin ZC et al. The prevalence of erectile dysfunction in 1247 married men in Beijing urban area. Chin J Urol 2003; 24: 855-7.
2. Hu DY, Chen H. Nie XY, Liu MY, Wu Y et al. Prevalence of erectile dysfunction among outpatients in Beijing. Chin J Med Guide 2003; 5: 194-7.
3. Fu JX, Chen BC, Wang WM, Liu CP, Zhu W. The incidence of erectile dysfunction in Nanning and Yulin of Guangxi Province. Chin J Urol 2001; 22: 376-7.
4. Wang JH, Tang CW, Yu XW, Deng XF, Ye HL et al. A prevalence survey of erectile dysfunction in elderly male. Chin J Geriatr 2004; 23: 426-7.
5. Liu L, Liu CS, Pang LN, Shao JB, Wang XJ et al. Analysis of correlative risk factors for diabetic erectile dysfunction in patients. Chin J Diabetes 2006; 14: 450-1.
6. Xu QQ, Zhu JJ, Jiang H. A clinical analysis of 140 cases of erectile dysfunction. Chin J Urol 2000; 21: 686-7.
7. Zhang QJ, Zhu JC, Xu QQ, Jiang H. Male sexual function study in three Chinese cities on 2226 males. Chin J Androl 2003; 17: 191-3.
8. Liu DF, Jiang H, Hong K, Zhao LM, Ma LL et al. Epidemiological changes of ED patients: investigations in 11 Chinese cities during the past 5 years. Natl J Androl 2009; 15: 724-6.
9. Wan Q, Zhu XW, Chen ZD, Xue J, Tang QL et al. NEVATM system for diagnosis of erectile dysfunction. Chin J Urol 2002; 23: 699.
10. Li JB, Shen Q, Huang DZ, Zhang QP, Shi XH et al. Evaluation of helicine arteries in patients with erectile dysfunction using color Doppler ultrasonography. Chin J Ultrasound Med 2006; 22: 777-9.
11. Li ZH, Ci J, Wang P, Kong CZ, Liu TC et al. Application of VISER in the diagnosis of erectile dysfunction. Chin J Urol 2002; 23: 665-6.
12. Bai WJ, Qu HW, Wang XF, Mao X, Sun L et al. Diagnostic approaches of penile erectile dysfunction Chin J Urol 2002; 23: 662-4.
13. Guo YL, Zhu JC, Pan TM, Cao J, Jiang Y et al. Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction. Chin J Urol 2001; 22: 389-94.
14. Phase IV Study Group. Safety and efficacy of viagra in the treatment of erectile dysfunction in a post-marketing study. Chin J Urol 2003; 24: 134-7.
15. Jin J, He ZJ, Zhang K, Zhu JC, Jiang H et al. The effect of vardenafil, a new potent highly selective phosphodiesterase type 5 inhibitor in the treatment of erectile dysfunction. Chin J Urol 2005; 26: 54-8.
16. Guo YL, Zhu JC, Pan TM, Ding Q, Wang YX et al. Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men. Int J of Urol 2006; 13: 721-7. (Pubitemid 43926762)
17. The Collaborative Study Group for Multi-Center Clinical Study of ED in China. Prevalence of erectile dysfunction in type 2 diabetic men and evaluation of efficacy and safety of sildenafil treatment. Chin J Endocrinol Metab 2005; 21: 348-52.
18. Jiang H, Xu QQ, Zhu JC. Effect of alprostadil urethral suppository on erectile dysfunction: a double blind, randomized, flexible dose escalation study for 78 patients. Chin J of Androl 2000; 14: 166-9.
19. Xin ZC, GUO YL, Choi HK. A retrospective study of 548 cases of erectile dysfunction treated by penile prosthesis implantation. Chin J Urol 2000; 21: 755-7.
20. Wang Q, Yang JX, Li GX, Xia ZY, Wang B et al. Multi-center and randomly controlled trial of Shuganyiyang capsules for the treatment of erectile dysfunction. J Beijing Univ TCM 2004; 27: 72-5.
21. Zhao YP, Bai WJ, Chen GQ, Liu SJ, Deng QP et al. Adenoviral gene transfer of antisense cDNA of the human PDE5A1 promoter gene to penis enhances erectile function in rabbits with diabetes mellitus. Chin J Urol 2005; 26: 562-5.
22. Gu FL. Epidemiological survey of benign prostatic hyperplasia and prostate cancer in China. J Beijing Med Univ 2000; 32: 30-3.
23. Li M, Zhang SW, Ma JH, Chen WQ, Na YQ et al. A comparative study on incidence trends of prostate cancer in part of cities and counties in China. Chin J Urol 2009; 30: 368-70.
24. Li M, Na YQ. The detection rate of prostate cancer in different prostate-specific antigen (PSA) levels in Chinese men. Natl Med J China 2008; 88: 16-8. (Pubitemid 351459702)
25. Gan WM, Chen HW, Wang ZM, Zhang N, Taiji N et al. Clinical significance of cytology of prostatic fluid in diagnosis of prostate carcinoma. J Fourth Mil Med Univ 2007; 28: 1677-9.
26. Cai L, Zhou LQ, He ZS, Li NC, Song Y et al. Predictive accuracy of different Partin tables in Chinese prostate cancer patients. Chin J Urol 2009; 30: 202-6.
27. Liu T, Wang XY, Wang Y. Multivariate survival analysis model of prostate cancer with a cox model. J Peking Univ (Health Sci) 2009; 41: 184-7.
28. Shan ZG, Jin J, Guo YL. Impaction of different prostate biopsy strategies on tumor detection. Chin J Urol 2006; 27: 40-2.
29. Hong K, Ma LL, Huang Y, Wang GL, Liu L. Risk factors for positive surgical margins in extraperitoneal laparoscopic radical prostatectomy. Chin J Urol 2008; 29: 272-4.
30. Qiu Z, Sun YC, Shao Q, Zhang Y, Du LD. Assessment of castrate testosterone levels in patients with advanced prostate cancer. Chin J Urol 2006; 27: 125-7.
31. Chen J, Xu DF, Gao T, Ren JZ, Yao YC et al. The survival and prognosis of three common treatments for prostate carcinoma and the factors impacting on them. China Oncol 2009; 19: 512-6.
32. He LY, Wang Y, Tang YX, Jiang XZ. A survey of urologists and andrologists diagnostic and treatment practices for chronic prostatitis in Hunan Area. Chin J Androl 2008; 22: 9-11.
33. WuLX, Liang CC, Tang ZG, Hao ZY, Liu P et al. Epidemiological study on psychological problems of 1426 patients with chronic prostatitis. Chin J Urol 2006; 27: 512-5.
34. Zhang TF, Liang CC, Ge WW, Hao ZY, Zhang XS et al. Impact of chronic prostatitis-like symptoms on quality of life of patients. Anhui Med J 2009; 30: 2-5.
35. Hu XP, Bai WJ, Zhu JC, Wang XF. A pathogenic and immunologic study of chronic prostatitis. Chin J Urol 2002; 23: 29-31.
36. Chen GH, Li LQ, Wang CH, Zhou Q, Hu LS. Correlation between the symptom index of chronic prostatitis and the amount of WBC and SPL in prostatic secretion. Chin J Human Sex 2009; 18: 17-8.
37. Liu XZ, Li SQ. Vasal sterilization in China. Contraception 1993; 48: 255-65.
38. Zhang LC, Li XA, Feng XS, Chai XG, He JB et al. Antifertility effect induced by small dosage injection of sodium morrhuate toward epididymis via vas deferens. Natl J Androl 1994; 1: 20-3.
39. Fan JC, Wei GY. Clinical analysis of 1000 male sterilization volunteers with ring clip. J Binzhou Med Coll 2001; 24: 282-3.
40. Shi QZ, Liu YR, Zhou RX. Epidemiological study on effect and safety of vas ligation with ring clip. J Binzhou Medical Coll 1991; 1: 7.
41. Yi EB, Mao PX, Zhao L, Zhao ZX, Yuan XS et al. The electric coagulation vasectomy for sterilization: an experimental study and its clinical application.Chin J Androl 1988; 3: 6.
42. Yin SG, Zhang CH, Liu HJ. Analysis of 347 male sterilization with electric coagulation. J Binzhou Med Coll 1997; 20: 185-6.
43. Sun ZH, Yin SG, Li DR, Zhang B, Wu SH et al. Clinical study of laser photocoagulation for vas occlusion. Chin J Surg 2005; 2: 112-4.
44. Yin SG, Sun ZH, Liu HJ, Zhang H, Wang YQ. A study of Ar1 laser photocoagulation for vas occlusion: 58 cases report. Chin J Androl 2006; 20: 55.
45. Xiao XM, Zhang DY, Xiao H, Wang PX, Yang ZW et al. The experiment and clinical observation of laser ductus deferens contraception. Chin J Androl 2008; 22: 15-8. (Pubitemid 351579001)
46. Deng YG, Hou YH, Yang YF, Zhou CL, Liu SZ. Clinical study of reversal intra-vas device with switch. Reprod Med 1994; 3: 53.
47. Liu XH, Zhan BY, Wu RY. Histological and ultrastructural observations on testes and epididymis in rhesus monkeys after two vasal contraceptive operations. Nan Xing Xue Za Zhi 1992; 6: 70-3.
48. Ye Y, Chen ZW, Xing ZJ, Wu YW. Experimental study of intra vas device for male sterilization in rat. Chin J Fam Plann 1998; 12: 543-5.
49. Song L, Gu Y, Lu W, Liang X, Chen Z. A phase II randomized controlled trial of a novel male contraception, an intra-vas device. Int J Androl 2006; 29: 489-95. (Pubitemid 44060732)
50. Huang XB, Suo JP, Chen CY, Dun QL, Shun JY et al. Influence of filtering nano-copper complex/polymer composites intra-vas device on the semen of male dog. Reproduction Contracept 2007; 27: 31-3.
51. World Health Organization Task Force for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril 1996; 65: 821-9.
52. Gu YQ, Liang XW, Wu WX, Peng L, Song SX et al. Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men. J Clin Endocrinol Metab 2009; 94: 1910-5.
53. Gu YQ, Tong JS, Ma TZ, Liu ML, Yuan D et al. Male hormonal contraception: effects of injections of testosterone undecanoate and depot medroxyprogesterone acetate at 8-week intervals in Chinese men. J Clin Endocrinol Metab 2004; 89: 2254-62. (Pubitemid 38619861)
54. Jian NM, Li YB, Feng L, Xin LM, Hong CL. An epidemiological survey on the primary infertility in Guizhou Province. Chin J of Fam Plann 2010; 1: 33-5.
55. Chen LF, Wang MZ, Yang WX, Gan SX, Tong ZJ et al. An epidemiological survey and clinical research on the primary infertility in Henan Province. Reprod Contracept 1992; 12: 51-4.
56. Xu YJ, Liu DM, Su QC, Sun MZ, Tian KW. An epidemiological investigations on the primary infertility of the three rural in Shandong Province. Chin J Fam Plann 2000; 65: 414-24.
57. Wang YB, Liu YH, Zhang YW. Study on current status of infertile couples in Zhabei District of Shanghai. Chin J Fam Plann 2002; 7: 410-3.
58. Chinese Women and Children Development Center and the China Population Association. Investigation on Infertility in China. Beijing: Chinese Women and Children Development Center and the China Population Association; 2009.
59. Vogt PH. Molecular genetics of human male infertility: from genes to new therapeutic perspectives. Curr Pharm Des 2004; 10: 471-500. (Pubitemid 38196180)
60. Xia XY, Yang B, Cui YX, Huang YF. Genetic causes of male infertility. Natl J Androl 2008; 14: 837-41.
61. Zhang J, Qiu SD. Male infertility-related genes. Int J Fam Plann (Reprod Health) 2006; 25: 221-4.
62. Wang LQ, Huang HF, Jin F, Qian YL, Cheng Q. High frequency of Y chromosome microdeletions in idiopathic azoospermic men with high follicle-stimulating hormone levels. Fertil Steril 2005; 83: 1050-2.
63. Liu XR, Li SW, Li L. Research progress in the psychological aspects and related interventions in infertile couples. J Reprod Med 2005; 14: 125-8.